Stay updated on TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Sign up to get notified when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.

Latest updates to the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded Revision v3.3.2 to the study record history and removed Revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the general funding/operating status notice from the page header.SummaryDifference0.7%

- Check49 days agoChange DetectedThe old and new screenshots show the same study record page with no visible updates to core study data such as title, status, eligibility, locations, or outcomes. Any differences appear to be UI or formatting changes within the history view rather than substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a government-funding notice and current operating status details plus version update to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference12%

- Check78 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.3%

- Check92 days agoChange DetectedUpdated from v3.0.1 to v3.0.2 and removed the 'Back to Top' link; no core content changes are evident.SummaryDifference0.7%

Stay in the know with updates to TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.